Does OKT3 increase the risk of recurrent hepatitis B in patients transplanted for hepatitis B?

Liver Transpl. 2000 Nov;6(6):810-2. doi: 10.1002/lt.500060623.
No abstract available

Publication types

  • Review

MeSH terms

  • DNA, Viral / analysis
  • Graft Rejection / drug therapy*
  • Hepatitis B / surgery*
  • Hepatitis B / virology
  • Hepatitis B Surface Antigens / analysis
  • Hepatitis B virus / genetics
  • Hepatitis B virus / immunology
  • Humans
  • Immunization, Passive
  • Immunoglobulins / therapeutic use
  • Immunosuppressive Agents / adverse effects*
  • Liver Transplantation*
  • Muromonab-CD3 / adverse effects*
  • Recurrence
  • Risk Factors

Substances

  • DNA, Viral
  • Hepatitis B Surface Antigens
  • Immunoglobulins
  • Immunosuppressive Agents
  • Muromonab-CD3
  • hepatitis B hyperimmune globulin